The effect of enantiomers of beta-agonists on myofibroblast-derived vascular endothelial growth factor and other matrix components in the presence of dust-mite extract

Allergy and Asthma Proceedings

Volumn 29, Issue 2, 2008, Pages 182-188

  Frieri, Marianne ^a   Capetandes, Anthony ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

(S) albuterol; Beta agonists; Beta2 adrenergic receptor agonists; Enantiomers; Endothelial growth factor; Fibroblasts; VEGF

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; FIBRONECTIN; HOUSE DUST ALLERGEN; INTERLEUKIN 1; SALBUTAMOL; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; CONNECTIVE TISSUE CELL; DRUG EFFECT; DRUG POTENTIATION; FIBROBLAST; HUMAN; IMMUNOLOGY; METABOLISM; MITE; STEREOISOMERISM;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; BRONCHODILATOR AGENTS; CELLS, CULTURED; CONNECTIVE TISSUE CELLS; FIBROBLASTS; FIBRONECTINS; HUMANS; INTERLEUKIN-1; MITES; RECEPTORS, ADRENERGIC, BETA-2; STEREOISOMERISM; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 43149094677     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3096     Document Type: Article

References (55)

1. Handley D. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists. J Allergy Clin Immunol 104:S69-S76, 1999.
2. Mitra S, Ugur M, Ugur O, et al. (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol 53:347-354, 1998.
3. Agrawal DK, Ariyarathna K, and Kelbe PW. (S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells. J Allergy Clin Immunol 113:503-510, 2004.
4. Govinden R, and Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther 98:257-265, 2003.
5. Xu YD, Hua J, Mui A, et al. Release of biologically active TGF-betal by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 285:L527-L539, 2003.
6. Hacena M, Moll B, Goddwin C, et al. Assessment of 11-8, TNFa, TGFb, and nitric oxide release and expression from allergen and growth factor stimulated human pulmonary epithelial cells with budesonide. J Allergy Clin Immunol 111:1302-1340, 2003.
7. Hacena M, May B, Courtney S, et al.. IL-8, TGF and GMCSF production from ragweed and dust mite-stimulated human pulmonary epithelial cells with budesonide. Ann Allergy Immunol 90:79, 2003.
8. Puglisi G, Horne NS, Huang Y-C, and Frieri M. Transforming growth factor b1 production and expression from ragweed stimulated human alveolar epithelial cells: Modulation by budesonide, formoterol, and levalbuterol. Ann Allergy Immunol 94:P148, 2005.
9. Ameredes BT, and Calhoun WJ. Modulation of GM-CSF release by enantiomers of beta-agonists in human airway smooth muscle. J Allergy Clin Immunol 116:65-72, 2005.
10. Morishima Y, Nomura A, Uchida Y, et al. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am J Respir Cell Mol Biol 24:1-11, 2001.
11. Gizycki MJ, Adelroth E, Rogers AV, et al. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 16:664-673, 1997.
12. Evans RA, Tian YC, Steadman R, and Phillips AO. TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res 282:90-100, 2003.
13. Desmouliere A, Geinoz A, Gabbiani F, and Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103-111, 1993.
14. Noack F, Sotlar K, Thorns C, et al. VEGF-, KIT Protein- and neutral endopeptidase (NEP/CD10)-positive myofibroblasts-precursors of angiogenesis in chorioangiomas? Placenta 24:758-766, 2003.
15. Chintalgattu V, Nair DM, and Katwa LC. Cardiac myofibroblasts: A novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 35:277-286, 2003.
16. De Wever O, and Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 200:429-447, 2003.
17. Panettieri RA Jr. Cellular and molecular mechanisms regulating airway smooth muscle proliferation and cell adhesion molecule expression. Am J Respir Crit Care Med 158:S133-S140, 1998.
18. Lazaar AL, and Panettieri RA Jr. Airway smooth muscle: A modulator of airway remodeling in asthma. J Allergy Clin Immunol 116:488-495, 2005.
19. Davies DE, Wicks J, Powell RM, et al. Airway remodeling in asthma: New insights. J Allergy Clin Immunol 111:215-225, 2003.
20. Zhang XY, Zhu FX, Olszewski MA, and Robinson NE. Effects of enantiomers of beta 2-agonists on ACh release and smooth muscle contraction in the trachea. Am J Physiol 274:L32-L38, 1998.
21. Benoit H, Jordan M, Wagner H, and Wagner PD. Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression. J Appl Physiol 86: 1513-1518, 1999.
22. Ingram JL, Rice AB, Geisenhoffer K, et al. IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha. FASEB J 18:1132-1134, 2004.
23. Marini M, Avoni E, Hollemborg J, and Mattoli S. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. Chest 102:661-669, 1992.
24. Frieri M, Pergolizzi R, Millan C, et al. Cytosine, chemokine and nitric oxide (NO) release in stimulated small airway cells (SAEC) treated with beta-2 agonist enantiomers of albuterol. J Allergy Clin Immunol 105:S292, 2000.
25. Frieri M. Clinical and basic science research on allergic rhinitis and asthma from Nassau University Medical Center. Allergy Asthma Proc 22:167-172, 2001.
26. Frieri M. Airway epithelial cell release of cytokines-modulation by various therapeutic agents. Allergy Asthma 25:1-25, 2004.
27. Herbert CA, King CM, Ring PC, et al. Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p 1. Am J Respir Cell Mol Biol 12:369-738, 1995.
28. Wan H, Winton HL, Soeller C, et al. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin Exp Allergy 31:279-294, 2001.
29. Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 104:123-133, 1999.
30. Gizycki MJ, Adelroth E, Rogers AV, et al. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 16:664-673, 1997.
31. Knight D. Epithelium-fibroblast interactions in response to airway inflammation. Immunol Cell Biol 79:160-164, 2001.
32. Holgate ST, Davies DE, Lackie PM, et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 105:193-204, 2000.
33. Frieri M. Asthma concepts in the new mullenium: Update in asthma pathophysiology. Allergy Asthma Proc 26:83-88, 2005.
34. Masur SK, Dewal HS, Dinh TT, et al. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci USA 93:4219-4223, 1996.
35. Richter A, Puddicombe SM, Lordan JL, et al. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 25:385-391, 2001.
36. Wen FQ, Kohyama T, Liu X, et al. Interleukin-4- and interleukin-13- enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. Am J Respir Cell Mol Biol 26:484-490, 2002.
37. Tschumperlin DJ, Shively JD, Kikuchi T, and Drazen JM. Mechanical stress triggers selective release of fibrotic mediators from bronchial epithelium. Am J Respir Cell Mol Biol 28:142-149, 2003.
38. Batra V, Musani AI, Hastie AT, et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 34:437-444, 2004.
39. Saika S, Miyamoto T, Tanaka S, et al. Response of lens epithelial cells to injury: Role of lumican in epithelial-mesenchymal transition. Invest Ophthalmol Vis Sci 44:2094-2102, 2003.
40. Wan H, Winton HL, Soeller C, et al. Quantitative structural and biochemical analyses of tight junction dynamics following exposure of epithelial cells to house dust mite particles allergen Der p 1. Clin Exp Allergy 30:685-698, 2000.
41. Capetandes A, Horne NS, and Frieri M. Dermatophagoides extract-treated confluent type II epithelial cells (cA549) and human mesenchymal cell growth. Ann Allergy Asthma Imuunol 95:381-388, 2005.
42. Capetandes A, Zhuang M, Haque F, et al. Vascular endothelial growth factor is increased by human pulmonary cells stimulated with Dermatophagoides sp. extract. Allergy Asthma Proc 28:324-330, 2007.
43. Baramki D, Koester J, Anderson AJ, and Borish L. Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J Allergy Clin Immunol 109:449-454, 2002.
44. Pepe C, Foley S, Shannon J, et al. Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 116:544-549, 2005.
45. Pascual RM, and Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol 116:477-486, 2005.
46. Kaner RJ, and Crystal RG. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med 7:240-246, 2001.
47. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164:839-545, 2001.
48. Pham I, Uchida T, Planes C, et al. Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 283:L1133-L1142, 2002.
49. Louzier V, Raffestin B, Leroux A, et al. Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 284:L926-L937, 2003.
50. Vesey DA, Cheung C, Cuttle L, et al. Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. J Lab Clin Med 140:342-350, 2002.
51. Hocking DC. Fibronectin matrix deposition and cell contractility: Implications for airway remodeling in asthma. Chest 122: 275S-278S, 2002.
52. Agarwal AR, Mih J, and George SC. Expression of matrix proteins in an in vitro model of airway remodeling in asthma. Allergy Asthma Proc 24:35-42, 2003.
53. Wijelath ES, Rahman S, Murray J, et al. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J Vase Surg 39:655-660, 2004.
54. Birchler MT, Milisavlijevic D, Pfaltz M, et al. Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors. Laryngoscope 113:1231-1237, 2003.
55. Puxeddu I, Ribatti D, Crivellato E, and Levi-Schaffer E. Mast cells and eosinophils: A novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 116: 531-536, 2005.